With life expectancies reaching new heights, this day and age is seeing many more people enjoy longer and fuller lives. With a consequential increase in the amount of us who tick the ’60 and over’ box, this group is making up a higher percentage of our earth’s population than ever before. The Daily Mail recently published the finds of a UN report into global population, which predicted the number of over 60’s to reach the two-billion mark in less than 40 years; a number which will be greater than that of children. With the proportion of pensioners growing faster than the rest of the general population, we are being urged to prepare for the resulting increase in healthcare demands.
Alzheimer’s disease then, is surely a growing concern, being right up there with the most common and devastating conditions among the elderly. With so many lives affected by Alzheimer’s already – not only that of the sufferer’s but of their loved ones too – surely research into this terrible disease needs to be a top priority if this number is likely to rise even higher.
However, as much as we’d love it to be, conducting medical research is not a simple endeavor.
It takes a lot of time and vast amounts of money to collect a significant-enough amount of data to draw up results bearing any reliability. Staffing the research is also a problem, as often professionals on the front line of healthcare are needed, and taking them out of such valuable and pressing duties is difficult. So, as severe as some illnesses may be, it’s understandable why it’s a questionable investment of your own hard-earned money, as well as time and resources, in studies that may never take off.
The people behind the important drug trials in St. Petersburg believe it’s more than worthwhile however. They are working on medication that, if successful, will mark a major break-through in the treatment of Alzheimer’s, offering sufferers or potential sufferers at least a little hope. And in these situations, a little really can go a long way.
As incredibly advantageous as this would be for so many people who are to be diagnosed with the disease in the future, it also carries a benefit that, while of less magnitude for the human race, is significant in an economical way for your company. For the ever-grateful patients whose lives this medication will potentially save, there is not a price tag high enough to be put on it. However, there is a very solid value for investors and affiliated businesses too, who will not only receive their returns in the form of improved healthcare statistics, but also in a financial and acclamatory sense.
Thinking about investing in medical research yourself? Well we can’t think of a more rewarding investment to make, so to help you, we’ve compiled a comprehensive range of data capture services, enabling you to gather your data in the most timely and economical manner possible, while still ensuring the best quality of results. If you’re interested, but find the world of clinical trials and medical research a bit much to get your head around, then you should check out our project management services, who will help you get going.
Contributed by: Document Capture Co